These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 32596740

  • 1. In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae.
    Romanelli F, De Robertis A, Carone G, Dalfino L, Stufano M, Del Prete R, Mosca A.
    New Microbiol; 2020 Jul; 43(3):136-138. PubMed ID: 32596740
    [Abstract] [Full Text] [Related]

  • 2. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y.
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae.
    Davido B, Crémieux AC, Vaugier I, Gatin L, Noussair L, Massias L, Laurent F, Saleh-Mghir A.
    Int J Antimicrob Agents; 2023 Jan; 61(1):106702. PubMed ID: 36476965
    [Abstract] [Full Text] [Related]

  • 4. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae.
    Ojdana D, Gutowska A, Sacha P, Majewski P, Wieczorek P, Tryniszewska E.
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [Abstract] [Full Text] [Related]

  • 5. In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
    Gaibani P, Lewis RE, Volpe SL, Giannella M, Campoli C, Landini MP, Viale P, Re MC, Ambretti S.
    Int J Infect Dis; 2017 Dec; 65():1-3. PubMed ID: 28951106
    [Abstract] [Full Text] [Related]

  • 6. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.
    Huang Y, Sokolowski K, Rana A, Singh N, Wang J, Chen K, Lang Y, Zhou J, Kadiyala N, Krapp F, Ozer EA, Hauser AR, Li J, Bulitta JB, Bulman ZP.
    Antimicrob Agents Chemother; 2021 Aug 17; 65(9):e0069221. PubMed ID: 34152820
    [Abstract] [Full Text] [Related]

  • 7. Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient.
    Gaibani P, Gatti M, Rinaldi M, Crovara Pesce C, Lazzarotto T, Giannella M, Lombardo D, Amadesi S, Viale P, Pea F, Ambretti S.
    Int J Infect Dis; 2021 Dec 17; 113():213-217. PubMed ID: 34656787
    [Abstract] [Full Text] [Related]

  • 8. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae.
    Wu Y, Yu W, Chu X, Zhang J, Jia P, Liu X, Zhu Y, Xu Y, Yang Q.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0010724. PubMed ID: 38712934
    [Abstract] [Full Text] [Related]

  • 9. Acquisition of a Stable and Transferable blaNDM-5-Positive Plasmid With Low Fitness Cost Leading to Ceftazidime/Avibactam Resistance in KPC-2-Producing Klebsiella pneumoniae During Treatment.
    Huang J, Zhang S, Zhao Z, Chen M, Cao Y, Li B.
    Front Cell Infect Microbiol; 2021 Jun 04; 11():658070. PubMed ID: 34354959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.
    Zhang W, Guo Y, Li J, Zhang Y, Yang Y, Dong D, Zhu D, He P, Hu F.
    Antimicrob Resist Infect Control; 2018 Jun 04; 7():142. PubMed ID: 30479755
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Resistance to ceftazidime-avibactam in a KPC-2-producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25.
    Findlay J, Poirel L, Bouvier M, Gaia V, Nordmann P.
    Eur J Clin Microbiol Infect Dis; 2023 May 04; 42(5):639-644. PubMed ID: 36877262
    [Abstract] [Full Text] [Related]

  • 15. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.
    Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.
    Antimicrob Agents Chemother; 2018 Mar 04; 62(3):. PubMed ID: 29263067
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering.
    Barnes MD, Winkler ML, Taracila MA, Page MG, Desarbre E, Kreiswirth BN, Shields RK, Nguyen MH, Clancy C, Spellberg B, Papp-Wallace KM, Bonomo RA.
    mBio; 2017 Oct 31; 8(5):. PubMed ID: 29089425
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.